Dialysis: Definition, Indications, and Treatment Modalities
Dialysis is a life-sustaining renal replacement therapy (RRT) used when kidney function deteriorates to the point where metabolic waste removal, fluid balance, and electrolyte homeostasis cannot be maintained through conservative management alone.
What is Dialysis?
Dialysis is an artificial process that removes waste products, excess fluid, and corrects electrolyte and acid-base abnormalities when the kidneys can no longer perform these functions adequately. It does not replace all kidney functions and should be viewed as supportive therapy rather than a cure 1.
Primary Indications for Initiating Dialysis
Absolute Indications (Life-Threatening)
Initiate dialysis immediately when any of these conditions are present 2:
- Persistent hyperkalemia unresponsive to medical management
- Severe metabolic acidosis refractory to treatment
- Volume overload unresponsive to diuretic therapy (particularly with pulmonary edema)
- Overt uremic symptoms including:
- Pericarditis
- Severe encephalopathy
- Uremic bleeding
Relative Indications
Consider initiating dialysis for 3:
- Severe progressive hyperphosphatemia (>6 mg/dL) with symptomatic hypocalcemia 2
- Progressive protein-energy wasting despite optimized nutrition 1
- Inability to safely manage metabolic abnormalities with medical therapy 1
GFR-Based Timing
The decision should NOT be based solely on GFR level 1, 3. However, practical considerations include:
- Planning for dialysis access or preemptive transplantation when GFR <15-20 mL/min/1.73 m² 3
- Typical initiation range: GFR 5-10 mL/min/1.73 m² when symptoms are present 3
- Target single pool Kt/V of 1.4 per hemodialysis session for thrice-weekly treatment, with minimum delivered 1.2 1
Critical caveat: Starting dialysis at higher GFR levels without clear symptoms does not improve survival and may accelerate loss of residual kidney function, particularly with hemodialysis 1, 4.
Primary Treatment Modalities
1. Hemodialysis (HD)
Most common modality - approximately 90% of dialysis patients in the US receive in-center HD 5.
Mechanism: Blood is pumped through an extracorporeal circuit with a semipermeable membrane that removes waste by diffusion and excess fluid by ultrafiltration.
Standard regimen: 3-4 hours, three times weekly 1
Vascular access requirements (in order of preference):
- Native arteriovenous (AV) fistula (preferred - should be created when GFR <15-20 mL/min/1.73 m²)
- AV graft
- Central venous catheter (temporary solution)
Advantages:
- Efficient solute removal (uric acid clearance 70-100 mL/min) 2
- Performed by trained staff in-center
- Rapid correction of life-threatening abnormalities
Disadvantages:
- Requires vascular access with associated complications 1
- Risk of intradialytic hypotension
- Accelerates loss of residual kidney function 4
- Fixed schedule impacts quality of life
2. Frequent/Extended Hemodialysis Options
Short frequent HD (5-6 times weekly, shorter sessions):
- May improve quality of life and physiological parameters 1
- Warning: Increased risk of vascular access procedures and hypotension 1
Home long HD (6-8 hours, 3-6 nights weekly):
- Better for lifestyle flexibility 1
- Risks: Increased vascular access complications, caregiver burden, accelerated decline in residual function 1
Special indication: Pregnant women with ESKD should receive long frequent hemodialysis 1
3. Peritoneal Dialysis (PD)
Mechanism: Dialysate is instilled into the peritoneal cavity; the peritoneal membrane serves as the dialyzing membrane.
Key characteristics:
- Requires surgically placed peritoneal catheter 6
- Can be performed at home
- Continuous or intermittent exchanges
Advantages:
- Preserves residual kidney function longer than HD
- Better hemodynamic stability
- Greater patient autonomy and flexibility
- No vascular access needed
Disadvantages:
- Less efficient solute and fluid removal compared to HD 2
- Risk of peritonitis
- Requires adequate peritoneal membrane function
- Patient must be capable of performing exchanges or have caregiver support
When to avoid PD: Not suitable for tumor lysis syndrome or situations requiring rapid, high-efficiency solute removal 2
4. Continuous Renal Replacement Therapy (CRRT)
Primary use: Critically ill, hemodynamically unstable patients in ICU settings 2, 7
Advantages over intermittent HD in acute settings 2:
- Better hemodynamic stability (less hypotension)
- Superior fluid balance control
- Better azotemia control
- Facilitates nutritional support delivery
- Useful in ARDS and sepsis
Indications in specific contexts 2:
- Pulmonary edema in unstable patients
- Tumor lysis syndrome with cardiovascular instability
- Multi-organ failure
Alternative: Long-duration daily dialysis can substitute when CRRT unavailable 2
Critical Decision-Making Framework
When to Start Dialysis
Use this composite assessment approach 3, 8:
- Symptom evaluation: Uremic symptoms (nausea, vomiting, altered mental status, pericarditis)
- Laboratory parameters: Severe hyperkalemia, acidosis, hyperphosphatemia
- Volume status: Refractory fluid overload
- GFR level: Typically 5-10 mL/min/1.73 m², but NOT the sole criterion
- Quality of life assessment
- Patient preferences and goals of care
Shared Decision-Making Requirements
All patients must receive comprehensive education about 8:
- Available dialysis modalities (HD, PD, home options)
- Conservative management with end-of-life care
- Time-limited trial of dialysis
- Option to stop dialysis
Documentation required: Life expectancy discussions, quality of life expectations, and treatment goals should be documented and dated 8
Pediatric Considerations
Additional indication: Poor growth refractory to optimized nutrition and growth hormone is an indication for KRT in children 3
Preemptive transplantation preferred: Should be pursued at eGFR 5-15 mL/min/1.73 m² depending on age, size, and progression rate 3
Common Pitfalls to Avoid
Starting dialysis too early based solely on GFR: No survival benefit and may accelerate residual function loss 1, 4
Confusing dialysis adequacy with adequate patient care: Dialysis alone doesn't address anemia, nutrition, bone disease, or cardiovascular complications 1
Delaying vascular access creation: AV fistula should be placed when GFR <15-20 mL/min/1.73 m², as it requires 2-3 months to mature
Using peritoneal dialysis for tumor lysis syndrome: PD is inefficient for rapid solute removal needed in TLS 2
Failing to offer conservative management: This is a legitimate option for patients who decline dialysis and should include comprehensive supportive care 3, 8
Not involving patients in decision-making: Informed consent requires full explanation of all options, including not starting dialysis 8